Hepatic atrophy-hypertrophy complex due to Echinococcus granulosus

Koray Karabulut1, Ilgin Ozden, Arzu Poyanli

  • 1Department of General Surgery, Hepatopancreatobiliary Surgery Unit, Istanbul University, Istanbul, Turkey.

Insights

Hepatic hydatid disease caused by Echinococcus granulosus can lead to the atrophy-hypertrophy complex (AHC). This condition, involving liver atrophy and compensatory hypertrophy, has surgical implications for both cyst removal and bile duct exploration.

Area of Science:

  • Hepatobiliary Surgery
  • Parasitology
  • Radiology

Background:

  • Obstruction of major hepatic or portal veins, or biliary branches, causes the atrophy-hypertrophy complex (AHC).
  • The role of hydatid cysts in causing AHC is debated.
  • Hepatic hydatid disease is caused by Echinococcus granulosus.

Purpose of the Study:

  • To investigate whether hydatid cysts can cause the atrophy-hypertrophy complex (AHC).
  • To confirm AHC in hepatic hydatid disease using volumetric analysis.
  • To highlight surgical implications of AHC in patients with hepatic hydatid disease.

Main Methods:

  • Retrospective analysis of 370 patients undergoing surgery for hepatic hydatid disease.
  • Review of operative notes for recorded AHC.
  • Computed tomography (CT) volumetric analysis of liver hemilivers and cyst volumes in seven patients.

Main Results:

  • AHC was recorded in 16 patients (4.4%) with hepatic hydatid disease.
  • Cysts in the right hemiliver caused right-sided atrophy and left-sided compensatory hypertrophy.
  • Volumetric analysis confirmed AHC, with median cyst volume of 392 ml.

Conclusions:

  • Hepatic hydatid disease can cause the atrophy-hypertrophy complex (AHC).
  • AHC necessitates caution during pericystectomy due to proximity to vital structures.
  • Surgeons must consider hepatoduodenal ligament rotation in AHC patients during common bile duct exploration to prevent vascular injury.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...